New Study: Creating Two-Part Drug Pricing System Would Ensure Prices More Accurately Reflect How Patients Value Drugs
Value assessment frameworks, such as the one used by the Institute for Clinical and Economic Review, or ICER, assume that a centralized agency is necessary to determine a medicine's value.
- Value assessment frameworks, such as the one used by the Institute for Clinical and Economic Review, or ICER, assume that a centralized agency is necessary to determine a medicine's value.
- "An efficient market process is the only way to ensure that drug prices accurately reflect value.
- By creating a two-part drug pricing system, we can better reflect a drug's value for patients and insurers, ensure affordability, and provide incentives for future innovation," concluded Winegarden.
- Insurers would pay the access fee on behalf of patients, ensuring that everyone covered by the insurance can access the drug.